Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Janssen, AZ and Roche at ESMO

Janssen, AZ and Roche at ESMO In addition to using ESMO to post data that suggests Perjeta (pertuzumab) should be the new standard in breast cancer, the company also presented positive results for its investigational MEK inhibitor

Roche's Perjeta should be 'new standard' in breast cancer

Roche's Perjeta should be 'new standard' in breast cancer Adding Roche's Perjeta to therapy with Herceptin and docetaxel has a dramatic impact on survival in patients with HER2-positive metastatic breast cancer, according to new trial data. ... With the latest CLEOPATRA data in hand the argument for the

Dive in: gaining leadership in a therapeutic area

Dive in: gaining leadership in a therapeutic area neu (4B5) Rabbit Monoclonal Primary Antibody assay marketed by its subsidiary Ventana - used to detect breast cancer patients eligible for Herceptin, Perjeta and Kadcyla.

Back to the future

Back to the future In 2013, Roche's biologics sales totalled $29.2bn. These were led by established oncology brands such as Avastin and MabThera/Rituxan, along with emerging breast cancer therapies such as Perjeta

NICE rejects Roche's Kadcyla as "unaffordable"

NICE rejects Roche's Kadcyla as The company is facing the threat of biosimilar competition to Herceptin later this year and had its Perjeta (pertuzumab) breast cancer drug rejected by NICE in draft guidance published in 2013.

[ Previous 5 results ] 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics